Bilaketaren emaitzak - Roderich E. Schwarz

  • Erakusten 1 - 16 emaitzak -- 16
Findu emaitzak
  1. 1
    Profile of nintedanib in the treatment of solid tumors: the evidence to date

    Profile of nintedanib in the treatment of solid tumors: the evidence to date nork Niranjan Awasthi, Roderich E. Schwarz

    Argitaratua 2015
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial

    Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial nork Roderich E. Schwarz, David Smith

    Argitaratua 2005
    Testu osoa Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.

    Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. nork Roderich E. Schwarz, Jeffrey S. Groeger, Daniel G. Coit

    Argitaratua 1997
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Subcutaneously implanted central venous access devices in cancer patients

    Subcutaneously implanted central venous access devices in cancer patients nork Roderich E. Schwarz, Jeffrey S. Groeger, Daniel G. Coit

    Argitaratua 1997
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    BMS-754807, a Small-Molecule Inhibitor of Insulin-like Growth Factor-1 Receptor/Insulin Receptor, Enhances Gemcitabine Response in Pancreatic Cancer

    BMS-754807, a Small-Molecule Inhibitor of Insulin-like Growth Factor-1 Receptor/Insulin Receptor, Enhances Gemcitabine Response in Pancreatic Cancer nork Niranjan Awasthi, Changhua Zhang, Winston Ruan, Margaret A. Schwarz, Roderich E. Schwarz

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling

    Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling nork Niranjan Awasthi, Margaret A. Schwarz, Varun Verma, Clint D. Cappiello, Roderich E. Schwarz

    Argitaratua 2008
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer

    Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer nork Niranjan Awasthi, Stefan Hinz, Rolf A. Brekken, Margaret A. Schwarz, Roderich E. Schwarz

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Functional and phenotypic analysis of tumor-infiltrating. Lymphocytes isolated from human primary and metastatic. Liver tumors and cultured in recombinant interleukin-2

    Functional and phenotypic analysis of tumor-infiltrating. Lymphocytes isolated from human primary and metastatic. Liver tumors and cultured in recombinant interleukin-2 nork Shojiro Takagi, Kangnian Chen, Roderich E. Schwarz, Shunzaburo Iwatsuki, Ronald B. Herberman, Theresa L. Whiteside

    Argitaratua 1989
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement

    Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement nork Roderich E. Schwarz, Jordan Berlin, Heinz Josef Lenz, Bernard Nordlinger, Laura Rubbia‐Brandt, Michael A. Choti

    Argitaratua 2012
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    PG545, an Angiogenesis and Heparanase Inhibitor, Reduces Primary Tumor Growth and Metastasis in Experimental Pancreatic Cancer

    PG545, an Angiogenesis and Heparanase Inhibitor, Reduces Primary Tumor Growth and Metastasis in Experimental Pancreatic Cancer nork Katherine T. Ostapoff, Niranjan Awasthi, Bercin Kutluk Cenik, Stefan Hinz, Keith Dredge, Roderich E. Schwarz, Rolf A. Brekken

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement

    Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement nork Roderich E. Schwarz, Ghassan K. Abou‐Alfa, Jeffrey F. Geschwind, Sunil Krishnan, Riad Salem, Alan P. Venook

    Argitaratua 2010
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer

    Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer nork Niranjan Awasthi, Chenyue Zhang, Anna Schwarz, Stefan Hinz, C. Wang, Noelle S. Williams, Margaret A. Schwarz, Roderich E. Schwarz

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Apricoxib, a Novel Inhibitor of COX-2, Markedly Improves Standard Therapy Response in Molecularly Defined Models of Pancreatic Cancer

    Apricoxib, a Novel Inhibitor of COX-2, Markedly Improves Standard Therapy Response in Molecularly Defined Models of Pancreatic Cancer nork Amanda Kirane, Jason E. Toombs, Katherine T. Ostapoff, Juliet G. Carbon, Sara Zaknoen, Jordan Braunfeld, Roderich E. Schwarz, Francis Burrows, Rolf A. Brekken

    Argitaratua 2012
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Endothelial-Monocyte Activating Polypeptide Ii, a Novel Antitumor Cytokine That Suppresses Primary and Metastatic Tumor Growth and Induces Apoptosis in Growing Endothelial Cells

    Endothelial-Monocyte Activating Polypeptide Ii, a Novel Antitumor Cytokine That Suppresses Primary and Metastatic Tumor Growth and Induces Apoptosis in Growing Endothelial Cells nork Margaret A. Schwarz, Jessica J. Kandel, Jerald Brett, Jun Li, Joanne Hayward, Roderich E. Schwarz, Olivier Chappey, Jean-Luc Wautier, John A. Chabot, Paul Lo Gerfo, David M. Stern

    Argitaratua 1999
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases

    A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases nork Jeffrey Meyer, Ryan Foster, Naama Lev‐Cohain, Takeshi Yokoo, Ying Dong, Roderich E. Schwarz, William G. Rule, Jing Tian, Yang Xie, Raquibul Hannan, Lucien Nedzi, Timothy D. Solberg, Robert Timmerman

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) Phase II Intergroup Trial, N9945/CI-66

    Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/ National Surgical Adj... nork Steven R. Alberts, Mark S. Roh, Michelle R. Mahoney, Michael J. OʼConnell, David M. Nagorney, Lawrence D. Wagman, Thomas C. Smyrk, Timothy L. Weiland, Lily Lai, Roderich E. Schwarz, R Molina, Todor Dentchev, John S. Bolton

    Argitaratua 2010
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: